✦ LIBER ✦

Acute myeloid leukaemia after treatment with 90Y-ibritumomab tiuxetan for follicular lymphoma

✍ Scribed by Daniele Focosi; Nadia Cecconi; Giuseppe Boni; Enrico Orciuolo; Sara Galimberti; Mario Petrini

Book ID: 102259761
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 69 KB
Volume: 26
Category: Article
ISSN: 0278-0232
DOI: 10.1002/hon.849

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We report here a patient with relapsed follicular lymphoma who developed secondary acute myeloid leukaemia 15 months after radioimmunotherapy (RIT) with ^90^Y‐ibritumomab tiuxetan, the fifth described case to date. We review the literature for the potential causal relationship between RIT and secondary myelodysplastic syndromes/acute myeloid leukaemia. Copyright © 2008 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Follicular lymphoma at relapse after rit

Follicular lymphoma at relapse after rituximab containing regimens: comparison of time to event intervals prior to and after 90Y-ibritumomab-tiuxetan

✍ Francesco Cicone; Eleonora Russo; Andrea Carpaneto; John O. Prior; Angelika Bisc 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

## Abstract Radioimmunotherapies with Zevalin® (RIT‐Z) showed encouraging results in patients with relapsed/refractory follicular lymphoma (FL), leading frequently to failure‐free intervals longer than those achieved by the last previous therapy. We compared time‐to‐event variables obtained before

EANM procedure guideline for radio-immun

EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with90Y-radiolabelled ibritumomab tiuxetan (Zevalin)

✍ Jan Tennvall; Manfred Fischer; Angelika Bischof Delaloye; Emilio Bombardieri; Li 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 137 KB

External beam radiation therapy after 90

External beam radiation therapy after 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory CD20+ non-Hodgkin’s lymphoma

✍ T.E Justice; J.A Martenson; G.A Wiseman; T.E Witzig 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Safety and efficacy of external beam rad

Safety and efficacy of external beam radiation therapy for non-Hodgkin lymphoma in patients with prior 90Y-ibritumomab tiuxetan radioimmunotherapy

✍ Terry E. Justice; James A. Martenson; Gregory A. Wiseman; Thomas E. Witzig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Maintenance treatment with azacytidine f

Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

✍ Michael Grövdal; Mohsen Karimi; Rasheed Khan; Anni Aggerholm; Petar Antunovic; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB